Stage IIIA Lung Small Cell Carcinoma AJCC v7

specific

Stage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated

13

Centers

11

Active Trials

—

Cancer Funding

Top Centers for Stage IIIA Lung Small Cell Carcinoma AJCC v7(13)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
Active Research Program
57.3
2
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
Active Research Program
57.3
3
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
Active Research Program
57.3
4
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
57.3
5
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
Active Research Program
57.3
6
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
57.3
7
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
Active Research Program
57.3
8
Boston University Cancer CenterBoston, MA
Active Research Program
57.3
9
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
Active Research Program
57.3
10
Princess Margaret Cancer CentreToronto, ON
Active Research Program
57.3
11
BC CancerVancouver, BC
Active Research Program
57.3
12
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
34.8
13
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
34.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →